Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Mild injectionsite reactions (redness, itching, soreness) may occur with subcutaneous administration
8 Wegovy approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
Retatrutide is an investigational pharmaceutical agent currently under clinical development and does not hold a marketing authorisation from the MHRA or the European Medicines Agency (EMA)
He felt that the product mixed well but could benefit from more explicit guidelines for new users
Available 10 mg/0.5 mL Available according to the FDA and were receiving no reports of supply issues
US$ 27.56
US$ 25.42
US$ 28.54
